Production (Stage)
Tvardi Therapeutics, Inc.
TVRD
$29.09
-$3.79-11.53%
NASDAQ
| 03/31/2025 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Net Income | -4.91M | -30.70M | |||
| Total Depreciation and Amortization | -- | 42.00K | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 4.29M | 5.09M | |||
| Change in Net Operating Assets | -4.08M | -4.89M | |||
| Cash from Operations | -4.69M | -30.45M | |||
| Capital Expenditure | -- | -836.00K | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | 26.79M | |||
| Cash from Investing | -- | 25.95M | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | 1.01M | -685.00K | |||
| Cash from Financing | 1.01M | -685.00K | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -3.69M | -5.19M | |||